Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 207-209, January 2010

Management of a thoracic endograft infection through an ascending to descending extra-anatomic aortic bypass and endograft explantation

Presented at the Thirty-third Annual Meeting of the Southern Association for Vascular Surgery, Tucson, Ariz, Jan 14-17, 2009.

  • Paul J. Riesenman, MD, MS
  • ,
  • Mark A. Farber, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Mark A. Farber, MD, Associate Professor, Division of Vascular Surgery, University of North Carolina, CB #7212, 3024 Burnett-Womack Bldg, Chapel Hill, NC 27599-7212

Department of Surgery, Division of Vascular Surgery, University of North Carolina, Chapel Hill, NC

Received 11 June 2009; accepted 23 July 2009. published online 27 September 2009.

A 52-year-old man presented 33 months after thoracic aortic endovascular repair with hemoptysis and was found to have an aortobronchial fistula secondary to a mycotic aneurysm. The endograft infection was managed in a two-stage fashion. During the initial stage, the patient underwent an ascending-to-descending thoracic aortic bypass. Neither cardiopulmonary bypass, hypothermic circulatory arrest, nor aortic cross-clamping were used. During the same hospitalization, the patient underwent successful endograft explantation through a left thoracotomy. Imaging at 6 months demonstrated no anastomotic concerns and resolution of residual pulmonary inflammation. Thoracic aortic endograft infections necessitating endograft removal can potentially be successfully and safely managed without the need for cardiopulmonary bypass, hypothermic circulatory arrest, or interruption of aortic blood flow.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Competition of interest: Dr Farber a consultant for W. L. Gore and Associates, Inc, Cook Inc, and Medtronic Inc.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01569-9

doi:10.1016/j.jvs.2009.07.097

Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 207-209, January 2010